Navigation Links
Deep Brain Stimulation Clinic Expedites Patient Treatment at Muhammad Ali Parkinson Center
Date:2/20/2013

PHOENIX, Feb. 20, 2013 /PRNewswire/ -- The Muhammad Ali Parkinson Center in Phoenix has launched a new clinic aimed at streamlining the process for the growing number of patients who are potential candidates for Deep Brain Stimulation.

Deep Brain Stimulation (DBS) is a surgical treatment involving the implantation of a medical device called a "brain pacemaker," which sends electrical impulses to specific parts of the brain. DBS in select brain regions has provided remarkable therapeutic benefits for otherwise treatment-resistant movement and affective disorders such as Parkinson's disease, tremor and dystonia.

The new clinic, which is part of the Ali center at the Barrow Neurological Institute, offers patients a comprehensive resource for education, medical evaluation, psychological assessment, imaging, surgery and post surgical monitoring. The one-day a week clinic was launched in July to serve the increasing numbers of patients who travel from all over the nation for DBS evaluation and surgery.

"We have dramatically reduced the waiting and evaluation time for patients," says Rohit Dhall , MD, who heads the clinic. "In the past, waiting for evaluation and approval for this treatment could be frustrating for patients. So, we have added new resources to the Ali center and established this clinic. It has already become very popular with people from all over Arizona, and as far away as Illinois, Wyoming and Michigan."

Phoenix real estate and development broker Tommy Zuleger is a patient and fan of the new clinic. "The Ali clinic's process was very efficient," says Zuleger. "The best part of the process was having every physician who was involved in my case working together and talking often about my treatment. I know that DBS isn't a cure, but I feel better than I have in years and I hope that it will help to control my symptoms for years to come."

Dr. Dhall emphasizes that DBS is not an effective treatment for all patients. He says previously a patient could wait up to year to complete the evaluation process. Now, the wait time is four to six weeks. Barrow is a leader in the use of DBS to treat movement disorders. Neurosurgeons and neurologists at Barrow were involved in early clinical trials of the therapy and thus have deep experience that is hard to find in the emerging field.

The clinic is held on Thursdays and four Barrow neurologists manage the multidisciplinary assessments of patients. Before patients see the neurologists, they are provided comprehensive education about the treatment by fulltime educators.

"One of the most important aspects of the clinic is to manage the expectations of patients," says Margaret Anne Coles , program manager at the Ali center. "Many of these patients have never received basic information about Parkinson's and so we provide a lot of support and information, not only about DBS, but about the disease in general."

Dr. Dhall explains that the Barrow doctors immediately establish communication with the physicians who have referred their patients to the Ali center. "We focus on keeping the patient's referring doctors in the loop at all times, so that the patient has another medical resource during their recovery."

Barrow Neurological Institute at St. Joseph's Hospital and Medical Center in Phoenix, Arizona is an internationally renowned medical center that offers care for people from throughout the world with brain and spine diseases, disorders and injuries. U.S. News & World Report routinely lists St. Joseph's as one of the top hospitals in the nation for neurological and neurosurgical care.


'/>"/>
SOURCE Barrow Neurological Institute
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. NW Bio Takes Next Steps In Moving Forward With Its Phase III Brain Cancer Trial In Europe
2. BHR Pharma Investigational Traumatic Brain Injury Treatment Receives European Medicines Agency Orphan Medicinal Product Designation
3. Varian Medical Systems Supports Program to Tap Brain Power of Research and Development Community in Russia
4. Brain Resource Featured as Market Leader in SharpBrains New Report on The State of the Digital Brain Health Market 2012-2020
5. Cerecor Announces Option to Johns Hopkins Brain Science Institute DAAO Inhibitor Platform
6. Braincells, Inc. Announces the Successful Completion of a Multiple Ascending Dose Study of BCI-838, a Group II mGluR2/3 Antagonist, and the Companys Plans for a Proof-of-Concept Study in Patients with Treatment-Resistant Depression
7. Elbit Imaging Ltd. Announces InSightecs ExAblate Neuro System Awarded European CE Mark for Non-invasive Treatment of Neurological Disorders in the Brain
8. High Altitude Climbers at Risk for Brain Bleeds
9. Research Published in European Journal of Pharmacology Shows that Star Scientifics Anatabine Suppresses Brain Inflammation in Animal Model of Alzheimers Disease and in Blood
10. Easy on the Stomach: ALCAT Worldwide Sponsors Successful Conference on Gut, Brain & Autoimmune Disorders
11. Imaging Shows Some Brains Compensate after Traumatic Injury
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/27/2017)... and BOSTON , March 27, ... global pharmaceutical company and Paratek Pharmaceuticals, Inc. (Nasdaq: ... and commercialization of innovative therapies based upon tetracycline ... of sarecycline for the treatment of moderate to ... endpoints. Sarecycline is a once-daily, oral, narrow spectrum ...
(Date:3/27/2017)... Calif. , March 27, 2017  Impax Laboratories, ... has appointed Paul M. Bisaro as Impax,s ... the Company,s Board, effective March 27, 2017. Mr. Bisaro ... served as Interim President and Chief Executive Officer since ... of generic and branded pharmaceutical experience, Mr. Bisaro, 56, ...
(Date:3/27/2017)... -- PhaseRx, Inc. (NASDAQ: PZRX), a biopharmaceutical company developing ... children, today reported financial results for the fourth ... and provided an update on its corporate activities. ... during the fourth quarter of 2016 through the ... study, and with our lead development candidate, PRX-OTC, ...
Breaking Medicine Technology:
(Date:3/27/2017)... ... March 27, 2017 , ... ... weight management program at Women’s Excellence will help patients lose weight and keep ... exam. The specialists at Women's Excellence will measure BMI, body fat composition, ...
(Date:3/27/2017)... ... March 27, 2017 , ... ... nurses and supply chain professionals, will hold their first Northeast Regional AHVAP Meeting. ... Bundles.” , “Increasingly, supply chain and value analysis professionals have a ‘seat ...
(Date:3/27/2017)... ... March 27, 2017 , ... Sodium determination is ... complicated and require expert user knowledge. In a live webinar on April 11th ... simplified, yet highly accurate, determination of sodium. , It has long been known ...
(Date:3/27/2017)... ... March 27, 2017 , ... ... with opioids alone responsible for over 33,000 of the 52,404 drug-related deaths in ... Bill (AB) 1512, which proposes a tax on prescription opioids to fund drug ...
(Date:3/25/2017)... ... March 25, 2017 , ... Getting earned media coverage meaningful for ... , All through the year, Garden Media aims to provide material helpful to ... influencers and pitching client’s key messages to gain coveted media placements, Garden ...
Breaking Medicine News(10 mins):